Anne Marie Lindegaard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anne Marie Lindegaard has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Jeppe Friborg
Department of Oncology Copenhagen University Hospital Rigshospitalet Copenhagen Denmark
5 shared publications - Katrin Håkansson
Department of Oncology, Centre for Cancer and Organ Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
5 shared publications - Mogens Bernsdorf
Department of Oncology, Centre for Cancer and Organ Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
3 shared publications Anita Gothelf
Department of Oncology, Centre for Cancer and Organ Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
2 shared publications- Claus Andrup Kristensen
Department of Oncology, Centre for Cancer and Organ Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
2 shared publications - Ivan Richter Vogelius
Department of Oncology, Centre for Cancer and Organ Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
2 shared publications
Latest Publications
- Open Access
- 21 October 2026
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 226, 111830
Planned versus accumulated dose in radiotherapy of oropharyngeal carcinoma – Do recurrences occur in unintended cold spots?
- 21 October 2026
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 226, 111830
Open AccessPlanned versus accumulated dose in radiotherapy of oropharyngeal carcinoma – Do recurrences occur in unintended cold spots?
- Open Access
- 16 September 2026
- Published by Wiley in Head & Neck
Pattern of Failure in Nasopharyngeal Carcinoma After Radiotherapy in a Low‐Incidence Population: A DAHANCA Study
Background: Nasopharyngeal carcinoma (NPC) is uncommon in many populations. Most existing clinical evidence comes from endemic areas, where Epstein–Barr virus (EBV)‐associated subtypes predominate. We analyzed patterns of failure in a population‐based cohort from Denmark, a low‐incidence setting. Methods: Patients with NPC treated with curative intent between 2000 and 2018 were identified through the Danish Head and Neck Cancer Study Group (DAHANCA) database and subsequently validated. Results: We identified 331 patients. The 5‐year cumulative incidence of failure was 31.1% for any failure, 16.9% for locoregional failure, and 14.2% for distant failure. Distant failure occurred almost exclusively in locally advanced disease (Stage I: 0%; II: 4.2%; III: 21.1%; and IVa: 19.4%). Rates of any failure were comparable between EBV‐positive (29.7%) and EBV‐negative (32.0%) tumors. Conclusions: In this low‐incidence population, the likelihood of failure after primary radiotherapy for NPC did not differ by EBV status. Distant failure was largely confined to patients with locally advanced stages.
- 16 September 2026
- Published by Wiley in Head & Neck
Open AccessPattern of Failure in Nasopharyngeal Carcinoma After Radiotherapy in a Low‐Incidence Population: A DAHANCA Study
Background: Nasopharyngeal carcinoma (NPC) is uncommon in many populations. Most existing clinical evidence comes from endemic areas, where Epstein–Barr virus (EBV)‐associated subtypes predominate. We analyzed patterns of failure in a population‐based cohort from Denmark, a low‐incidence setting. Methods: Patients with NPC treated with curative intent between 2000 and 2018 were identified through the Danish Head and Neck Cancer Study Group (DAHANCA) database and subsequently validated. Results: We identified 331 patients. The 5‐year cumulative incidence of failure was 31.1% for any failure, 16.9% for locoregional failure, and 14.2% for distant failure. Distant failure occurred almost exclusively in locally advanced disease (Stage I: 0%; II: 4.2%; III: 21.1%; and IVa: 19.4%). Rates of any failure were comparable between EBV‐positive (29.7%) and EBV‐negative (32.0%) tumors. Conclusions: In this low‐incidence population, the likelihood of failure after primary radiotherapy for NPC did not differ by EBV status. Distant failure was largely confined to patients with locally advanced stages.
- 15 September 2023
- Published by Taylor & Francis in Acta Oncologica
- Vol. 62 (11) , 1369-1374
CBCT-based online adaptive radiotherapy for head and neck cancer – dosimetric evaluation of first clinical experience
- 15 September 2023
- Published by Taylor & Francis in Acta Oncologica
- Vol. 62 (11) , 1369-1374
CBCT-based online adaptive radiotherapy for head and neck cancer – dosimetric evaluation of first clinical experience
- Open Access
- 10 August 2023
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 62 (11) , 1360-1368
A systematic review on clinical adaptive radiotherapy for head and neck cancer
"Introducing canine lifestyle medicine and access to care in context of an interprofessional framework" published on 14 May 2023 by American Veterinary Medical Association.
- 10 August 2023
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 62 (11) , 1360-1368
Open AccessA systematic review on clinical adaptive radiotherapy for head and neck cancer
"Introducing canine lifestyle medicine and access to care in context of an interprofessional framework" published on 14 May 2023 by American Veterinary Medical Association.